As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of OXBRIDGE RE HOLDINGS Ltd. The largest reported stake is Martin Allan S.'s, at 9.3%. 3 filings are on record since July 8, 2025 (Schedule 13D/A, April 17, 2026).
Sell to companies like OXBRIDGE RE HOLDINGS Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Martin Allan S. · Sole voting: 0 · Shared voting: 760,960 · Sole dispositive: 0 · Shared dispositive: 760,960 · SCHEDULE 13D/A, 2026-04-17
- · Reporting person: Armistice Capital, LLC · Sole voting: 0 · Shared voting: 395,792 · Sole dispositive: 0 · Shared dispositive: 395,792 · SCHEDULE 13G/A, 2025-08-14
- · Holder: Martin Allan S. · Percent: 12.1% · SCHEDULE 13D/A
OXBRIDGE RE HOLDINGS Ltd has 3 Schedule 13D or 13G filings on record since 2025-07-08. 1 holder's latest filing reports 5% or more of ordinary shares. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 9.3% | 760,960 | SCHEDULE 13D/A, 2026-04-17 | 2026-04-16 | |
| Armistice Capital, LLC | 4.99% | 395,792 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
Holding shares or following this stake? See who's behind OXBRIDGE RE HOLDINGS Ltd and the warning signs.
Free to see. No signup.
Keep reading
More on OXBRIDGE RE HOLDINGS Ltd and the records around it.
OXBRIDGE RE HOLDINGS Ltd elsewhere on the record
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Watch OXBRIDGE RE HOLDINGS Ltd
Get an email when OXBRIDGE RE HOLDINGS Ltd files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on OXBRIDGE RE HOLDINGS Ltd?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on OXBRIDGE RE HOLDINGS Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on OXBRIDGE RE HOLDINGS Ltd covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Martin Allan S. | 0 | 760,960 | 0 | 760,960 | SCHEDULE 13D/A, 2026-04-17 |
| Marie B. Martin | 17,332 | 205,399 | 17,332 | 222,731 | SCHEDULE 13D/A, 2026-04-17 |
| Fleur de Lis Partners, LLLP | 0 | 317,770 | 0 | 317,770 | SCHEDULE 13D/A, 2026-04-17 |
| Allan S Martin Childrens IRRV Trust | 17,332 | 0 | 17,332 | 0 | SCHEDULE 13D/A, 2026-04-17 |
| Armistice Capital, LLC | 0 | 395,792 | 0 | 395,792 | SCHEDULE 13G/A, 2025-08-14 |
| Steven Boyd | 0 | 395,792 | 0 | 395,792 | SCHEDULE 13G/A, 2025-08-14 |
The latest filing identifies OXBRIDGE RE HOLDINGS Ltd by CUSIP G6856M106 and gives its principal executive office as SUITE 201, 42 EDWARD STREET, P.O. BOX 469, GEORGETOWN (SCHEDULE 13D/A, 2026-04-17).
Source of funds (Item 3)
The Reporting Persons used personal funds to purchase Ordinary Shares and warrants.Martin Allan S., SCHEDULE 13D/A, 2026-04-17
Purpose of Transaction (Item 4)
Martin Allan S.
All of the Ordinary Shares and Warrants of the Issuer were acquired for investment purposes.Item 4 of the SCHEDULE 13D/A filed 2026-04-17
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-08 | Martin Allan S. | 12.1% | SCHEDULE 13D/A |
| 2025-08-14 | Armistice Capital, LLC | 4.99% | SCHEDULE 13G/A |
| 2026-04-17 | Martin Allan S. | 9.3% | SCHEDULE 13D/A |
Questions about who owns OXBRIDGE RE HOLDINGS Ltd
Who owns OXBRIDGE RE HOLDINGS Ltd?
On this page, one holder's latest ownership filing reports 5% or more of OXBRIDGE RE HOLDINGS Ltd: Martin Allan S. (9.3%, Schedule 13D/A, filed 2026-04-17).
When did Martin Allan S. buy into OXBRIDGE RE HOLDINGS Ltd?
The filings give report dates, not purchase dates. The earliest filing from Martin Allan S. on this page is the Schedule 13D/A, filed 2025-07-08, reporting 12.1%; its latest, Schedule 13D/A filed 2026-04-17, reports 9.3%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for OXBRIDGE RE HOLDINGS Ltd. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.